Alira Health

Alira Health
Contact us
Alira Health
Menu
Home > Education Hub > Articles
Filtering options
ADC
Advanced Analytics
Advanced Therapies
Antibody-Drug Conjugates
Biologics
Biometrics
Biopharma
BioRegion
Biosimilars
Biostatistics
Biotech
Cardiology
CDD
CDMO
Cell & Gene Therapy (CGT)
Clinical
Clinical Operations
Clinical Trials
CMC
Co-Design
Complex Innovative Design
CRO
Crowdfunding
Data Science
Decentralized Clinical Trials
Dermatology
Diabetes
Diagnostics
Digital Health
Digital Therapeutics
Digital Transformation
Diversity
Drug Delivery
Drug Development
Due Diligence
eCOA
Environmental Policy
EU
European Medicines Agency
France
Funding
Genomic Testing
Health Economics
Health Policy
Healthcare Technology
HEOR
Hospitals
Hybrid Clinical Trials
In-Vitro Diagnostic Regulation
Innovation
Investor Relations
ISE/ISS
Italy
IVDR
Life Sciences
Lifecycle Optimization
Lupus
M&A
Market Access
Medical Devices
Medical Robotics
MedTech
Mobile Tech
Myasthenia Gravis (MG)
Nuclear Medicine
Oncology
Orphan Drug
Orthopedic
Outcomes Research
Outsourcing Clinical Trials
Patient Advocacy
Patient Centricity
Patient Engagement
Patient-Enabled Innovation
Pharma
Press Release
Pricing
Product Development
Radioligand Therapies (RLTs)
Radiopharmaceuticals
Rare Disease
Real-World Evidence (RWE)
Registry-based studies
Regulatory
Research & Development
Research and Development
Robotic-Assisted Surgery (RAS)
RWE Decision Alert
Spain
Startups
Strategic Expansion
Sustainability
Therapeutics
Transaction Advisory
UK
USA
Vaccines
Value-Based Contracts
Wound Healing
All

Articles

Articles February 17, 2025
Rethinking Rare Disease Development: An Integrated, Patient Access-Driven Approach
Explore how biotech companies can succeed in rare disease by integrating development, commercialization, and patient access.
Patient Centricity Pharma Rare Disease
Articles February 11, 2025
From Diagnosis to Long-Term Care: Navigating the Rare Disease Journey
For Rare Disease Day, we spoke with patient engagement expert Luca Trentin on challenges faced by rare disease patients and how pharma can better understand their needs.
Patient Centricity Pharma Rare Disease
Articles December 10, 2024
2024 Antibody-Drug Conjugates Landscape: Market Expansion, Innovations, and Strategic Acquisitions
Antibody-Drug Conjugates (ADCs) have emerged as a groundbreaking strategy in precision oncology, uniquely merging the specificity of antibodies with the potency of cytotoxic drugs.
ADC Antibody-Drug Conjugates Pharma
Articles August 13, 2024
Nuclear Medicine Market in 2024: Challenges and Opportunities
What are the answers to some frequently asked questions about challenges and opportunities in the nuclear medicine market in 2024 and beyond?
Nuclear Medicine Oncology Pharma
Articles November 17, 2023
Misconceptions About Patient-Centric Co-Design
Many people have misconceptions about patient-centric co-design, and these misconceptions are holding companies back.
Co-Design Digital Health MedTech Patient Centricity Pharma
Articles November 2, 2023
The Impact of New Treatment Approvals in Oncology on Relative Survival Rates for EU Patients
This article explores the relationship between the number of new cancer treatment approvals and the five-year relative survival of cancer patients across the European Union (EU).
Oncology Pharma
Articles October 16, 2023
How to Co-Design a Solution with Patients to Meet Their Needs
To learn how you can benefit from a co-design approach and how to get started, we spoke with two experts on patient engagement and co-design.
Co-Design Digital Health MedTech Patient Centricity Patient Engagement Pharma
Articles October 9, 2023
Inflation Reduction Act and Pharma – Navigating Uncertainty
What's the impact of the Inflation Reduction Act on small biotechs, mid-size companies and large pharma players, and how can they prepare?
Biotech Pharma
Articles July 24, 2023
What EU Companies Need to Know about the U.S. Inflation Reduction Act
We spoke with our inhouse experts to learn about the significance of the US Inflation Reduction Act for EU pharma and biotech companies.
Biotech Drug Development Pharma
Articles June 30, 2023
Why You Need Market Access and How to Get Started
Start reading to learn about the importance of market access in pharma and MedTech and the key steps to get started.
Market Access MedTech Pharma
Articles April 17, 2023
Reimbursement of Rare Disease Drugs in Italy: Challenges and Hopes for the Future
When it comes to rare diseases, Italy has done a good job in bringing EMA-approved drugs, including orphan drugs, to the Italian market. But  multiple challenges exist, many of which(...)
Italy Market Access Pharma Rare Disease Real-World Evidence (RWE)
Articles April 17, 2023
Pharmaceutical Market Access in the UK: A Changing Landscape
Start reading this interview with Rachel Fyson to gain insight into the changing landscape of market access in the United Kingdom.
Market Access Pharma UK
Articles April 3, 2023
Today’s Digital Health Solutions Landscape
We spoke with Fabrizio Bellina, Director of Digital Solutions at Alira Health, to learn more about the challenges facing and MedTech companies as they look to bring digital health solutions(...)
Digital Health Italy MedTech Pharma
Articles March 20, 2023
The State of Market Access in Italy 2023
To learn about the state of market access in Italy today, we spoke with Giovanni Firenze, Director of Market Access Italy for Alira Health, who attended the recent 2023 Conferenza Nazionale(...)
Drug Development Italy Market Access Pharma
Articles February 28, 2023
Impact of the Orphan Drug Act on Rare Disease Patients and the Pharmaceutical Industry
On the 40th anniversary of the Orphan Drug Act (ODA) in the United States, we asked Alira Health’s Jennifer Lannon, Director of Patient Advocacy and Partnerships, and Xavier Prugnard,(...)
Orphan Drug Pharma Rare Disease
Articles January 20, 2023
Insights on Market Access
To get her perspective on market access and what to expect in 2023, we spoke with Nerea Blanqué, Senior Vice President of Market Access and Pricing at Alira Health.
Market Access Medical Devices Pharma
Articles January 18, 2023
The State of Biopharma Funding
We spoke with Joris Pezzini, Executive Vice President of Biopharma, Alira Health, during the J.P. Morgan Healthcare Conference in San Francisco, which brings together investors and(...)
Biopharma Biotech Funding Pharma
Articles December 21, 2022
2022 Recap: Your Favorite Alira Health Publications
In 2022, the Alira Health team of scientists, strategists, economists, clinicians, and biostatisticians shared actionable insights, industry thought leadership, and leading-edge guidance(...)
Clinical Digital Health Market Access MedTech Pharma Regulatory
Articles August 25, 2022
Why—and When—to Use a CDMO
Pharmaceutical development companies of all sizes frequently outsource their Active Pharmaceutical Ingredient (API) manufacturing to CDMOs for various reasons. In this article, we explore(...)
CDMO Pharma Research and Development
Articles June 23, 2022
Developing Data Specialist Talent: Collaboration Is Key
Companies across Pharma and MedTech need talented people to cover the range of data-related challenges. Discover what this means for developing talent throughout the industry.
MedTech Pharma
Articles March 31, 2022
FDA Project Orbis and Delivery of New Oncology Drugs to Market
Are you developing an oncology drug? Project Orbis, a program coordinated by the U.S FDA, allows you to register your product in several countries with a single submission. Find out(...)
Drug Development Oncology Pharma Regulatory

Latest from Alira Health

Case Studies Events News Reports Scientific Articles Webinars
Case Studies March 20, 2025
Pharma Company Defines Advocacy Strategy Through Data-Driven Patient Association Mapping
Alira Health mapped 253 CVRM patient advocacy groups across 11 countries, delivering a data-driven strategy to optimize partnerships, advocacy efforts, and differentiation.
Patient Advocacy Patient Engagement Pharma
Case Studies March 6, 2025
Rare Disease Pharma Maps Rare Cholestatic Liver Disease Journey for Targeted Patient Engagement
A global pharmaceutical company specializing in rare diseases, oncology, and neuroscience sought to analyze the patient journey for progressive familial intrahepatic cholestasis (PFIC).
Patient Centricity Pharma Rare Disease
Case Studies October 31, 2024
Family Office Optimizes Biosimilar Investments Through Strategic Capital Market Transaction
A client reached out to appropriately value two biosimilar assets, facilitate discussions with its management, and coordinate the capital market transaction as an asset-contribution in kind.
Biologics Transaction Advisory
Events April 22, 2025
2025 SNMMI Annual Meeting
Connect with our delegates onsite to discover how we can support you in developing nuclear medicine solutions.
Nuclear Medicine USA
Events April 22, 2025
MEET2WIN 2025
Discover how we can help you accelerate innovation and deliver tomorrow’s standard of care for oncology patients.
Clinical EU Oncology Real-World Evidence (RWE) Transaction Advisory
Events April 1, 2025
The Medtech Forum 2025
Connect with our experts to learn how we can help accelerate patient access to your innovations.
EU HEOR MedTech Pricing
News February 27, 2025
Alira Health Oversees the Digital Development of Gustave Roussy’s Project Interception to Advance Cancer Prevention
Alira Health, a global healthcare advisory and technology company, is proud to collaborate as a commercial partner with the digital development of Project Interception, a pioneering(...)
Healthcare Technology Patient Centricity Patient-Enabled Innovation Real-World Evidence (RWE)
News January 14, 2025
Alira Health Launches SpherePX™, a Next-Generation Technology Platform to Advance Real-World Evidence
Alira Health announces the global launch of its innovative technology platform SpherePX, designed to drive real-world evidence (RWE) collection and elevate patient engagement and retention.(...)
Healthcare Technology Patient Centricity Patient-Enabled Innovation Real-World Evidence (RWE)
News January 8, 2025
Alira Health Launches the Global Payer Forum 2025 in Partnership with UPF Barcelona School of Management, NEWDIGS at Tufts Medical Center, and the University College of London
Alira Health is excited to announce the second year of the Global Payer Forum, a landmark educational initiative in partnership with distinguished academic institutions, UPF Barcelona(...)
Health Policy Market Access Pharma
Reports January 28, 2025
Nuclear Medicine in 2024: A Year of Breakthroughs and Challenges
Nuclear medicine is entering a game-changing era. Breakthroughs in radiopharmaceuticals, cutting-edge clinical advancements, and surging investments are propelling the field forward.
Nuclear Medicine Oncology Radiopharmaceuticals
Reports December 12, 2024
Biologics and Advanced Therapies Contract Manufacturing: Public Market Update
Gain a comprehensive analysis of publicly traded companies in the sector, including the performance and strategies of global leaders, regional specialists, and niche innovators, providing(...)
Advanced Therapies Biologics CDMO
Reports November 29, 2024
The 2024 Global Antibody-Drug Conjugates Report
Gain comprehensive insights into the ADC market with our 2024 Global Antibody-Drug Conjugates Report. This in-depth analysis covers market trends, clinical development challenges, innovation(...)
ADC Antibody-Drug Conjugates Pharma
Scientific Articles March 7, 2024
Randomized Controlled Trial Evidence of Cost-Effectiveness of a Multifaceted AKI Intervention Approach
Acute kidney injury (AKI) is linked to elevated healthcare usage and greater expenses. The Tackling AKI study, a pragmatic, multicenter, stepped-wedge cluster randomized trial, showcased(...)
Advanced Analytics Clinical Trials
Scientific Articles December 18, 2023
Best Practices for Health Technology Assessment of Robotic Assisted Surgery
An expert panel developed seven best-practice recommendations for evaluating Robotics Assisted Surgical systems and here are the results.
Healthcare Technology HEOR Medical Robotics
Scientific Articles November 20, 2023
Therapeutic IgG-Like Bispecific Antibodies: Modular Versatility and Manufacturing Challenges
Our experts conducted a deep evaluation of IgG-like bsAbs including general advantages and disadvantages compared with MAbs and more.
CMC
Webinars March 28, 2025
How Sustainability and Health Equity Are Reshaping Market Access Policy in Europe
This webinar will explore sustainability and health equity impact on reimbursement and procurement decisions in Europe and provide practical insights on how companies can adapt to the new landscape.
EU Market Access Sustainability
Webinars October 3, 2024
The Lupus Journey: Addressing Unmet Patient Needs
This webinar will help you translate insights of the lupus patient journey into value-added takeaways for your lupus asset.
Lupus
Webinars September 10, 2024
Developing an Effective Regulatory Strategy for the Evolving 2024 Medtech Landscape
This webinar explores how to manage the growing regulatory demands and crucial differences between the EU and US regulatory landscapes, and the latest updates that could impact your business
MedTech Regulatory
View all Case Studies
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.